Spectral MD Holdings to get $18.8mn additional finding from BARDA
LONDON, U.K: Spectral MD Holdings (SMD) announced the commitment of additional funding of $18.8 million from the US Biomedical Advanced Research and Development Authority (BARDA), which will be used to expand the current clinical training study of Spectral MD’s DeepView…